Produkty 5589-41-3

CAS 5589-41-3 występuje w naszej ofercie pod nazwami: Dihydrowithaferin A/ 99.39% (existing batch purity), Dihydrowithaferin A, Dihydrowithaferin A, Dihydrowithaferin A, 99.85% ,, 99.85% ,, Dihydrowithaferin A, 99.72%. Oferty producentów: TargetMol, GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 5 mg, 10 mg.

Dihydrowithaferin A/ 99.39% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
od 784,16
Zobacz produkt
Dihydrowithaferin A
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 901,27
Zobacz produkt
Dihydrowithaferin A
Biosynth
  • opakowanie: 25mg, 50mg
  • Warianty: 2
Zobacz produkt
Dihydrowithaferin A, 99.85% ,, 99.85% ,
Chemat
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 4
od 626,00
Zobacz produkt
Dihydrowithaferin A, 99.72%
MedChemExpress
  • opakowanie: 5 mg, 10 mg
  • Warianty: 2
od 1225,27
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

6-hydroxy-15-[1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-3-one (CAS 5589-41-3) to związek chemiczny o wzorze sumarycznym C28H40O6 i masie molowej 472.6 g/mol. Nazwa systematyczna IUPAC: 6-hydroxy-15-[1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-3-one. InChIKey: YRXCLNDPESBJHL-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H40O6
Masa molowa472.6 g/mol
Nazwa IUPAC6-hydroxy-15-[1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-3-one
InChIKeyYRXCLNDPESBJHL-UHFFFAOYSA-N
SMILESCC1=C(C(=O)OC(C1)C(C)C2CCC3C2(CCC4C3CC5C6(C4(C(=O)CCC6O)C)O5)C)CO

Dane obliczone przez PubChem (NCBI)

Synonimy: Withaferin A, dihydro-, 2,3-Dihydrowithaferin-A
Izomery (ten sam wzór sumaryczny)
11,24-ditert-butyl-2,5,8,15,18,21-hexaoxatricyclo[20.4.0.09,14]hexacosa-1(22),9(14),10,12,23,25-hexaene C28H40O6
methyl (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate C28H40O6
5-[(1S)-1-[(1R,3aR,4R,7R)-7-(2-hydroxypropan-2-yl)-1,4-dimethyl-3,3a,4,5,6,7-hexahydro-2H-azulen-1-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H40O6
(3R,4aR,6aR,12aR,12bR)-3-(2-hydroxypropan-2-yl)-6a,12b-dimethyl-9-[(2S,4S)-4-methyl-3-oxohexan-2-yl]-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthene-8,11-dione C28H40O6
5-[(1R)-1-[(1aS,3aS,4S,7R,7aR,7bS)-7-hydroxy-1,1,3a,7-tetramethyl-1a,2,3,4,5,6,7a,7b-octahydrocyclopropa[a]naphthalen-4-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H40O6
2,4,6-trihydroxy-5-[1-[6-(2-hydroxypropan-2-yl)-8a-methyl-4-methylidene-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-yl]-3-methylbutyl]benzene-1,3-dicarbaldehyde C28H40O6
2,4,6-trihydroxy-5-[1-[6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-2,3,4,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylbutyl]benzene-1,3-dicarbaldehyde C28H40O6
2,4,6-trihydroxy-5-[1-[7-(2-hydroxypropan-2-yl)-1,4-dimethyl-3,3a,4,5,6,7-hexahydro-2H-azulen-1-yl]-3-methylbutyl]benzene-1,3-dicarbaldehyde C28H40O6
5-[(1R)-1-[(1aR,4R,4aR,7S,7aS,7bR)-4-hydroxy-1,1,4,7-tetramethyl-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H40O6
5-[(1S)-1-[(1S,4aS,6R,8aS)-6-(2-hydroxypropan-2-yl)-8a-methyl-4-methylidene-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H40O6
5-[(1S)-1-[(1aR,4R,4aR,7S,7aS,7bR)-4-hydroxy-1,1,4,7-tetramethyl-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H40O6
methyl (3S,5S,8S,9S,10R,13R,14R)-3-acetyloxy-17-hydroxy-4,4,8,10,12,13,16-heptamethyl-15-oxo-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-14-carboxylate C28H40O6